Eu Ivdr Eu Ivd Class B On The Market 🇺🇸 United States

Aptiva® APS IgM Reagent

Inova Diagnostics. Inc. · 🇺🇸 United States
Devices (same UDI-DI)
1
Certificates
0
Countries
20
Notified Bodies
0

Basic Information

Primary DI
08430793040853
Basic UDI-DI Code
843079304085345
Reference
725140
Device Types
Single use New device
Regulation
Eu Ivdr
Classification
Eu Ivd Class B
Status
On The Market

Additional Description

The Aptiva APS IgM Reagent is an immunoassay utilizing particle-based multi-analyte technology for the semi-quantitative determination of anti-cardiolipin (aCL) and anti-beta 2 glycoprotein 1 (aβ2GPI) IgM autoantibodies in human serum and citrated plasma as an aid in the diagnosis of primary and secondary antiphospholipid syndrome (APS), when used in conjunction with other laboratory findings. The Aptiva APS IgM Reagent is intended for use with the Aptiva Multi-Analyte System.

CND Nomenclature Codes

Code Description
W0102100503 ANTI-B2-GLYCOPROTEIN I ANTIBODIES
W0102100501 ANTI-CARDIOLIPIN ANTIBODIES

Available In Countries

🇦🇹 Austria 🇧🇪 Belgium 🇨🇾 Cyprus 🇩🇪 Germany 🇩🇰 Denmark 🇪🇸 Spain 🇫🇮 Finland 🇫🇷 France 🇭🇷 Croatia 🇮🇪 Ireland 🇮🇹 Italy 🇱🇮 Liechtenstein 🇱🇺 Luxembourg 🇱🇻 Latvia 🇲🇹 Malta 🇳🇱 Netherlands 🇵🇱 Poland 🇵🇹 Portugal 🇸🇮 Slovenia 🇬🇧 United Kingdom

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Class B) and regulation (EU IVDR).

View all